In hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC), both COX-2 and PPARα are overexpressed (Chen et al., 2004; Cervello and Montalto, 2006; Abu Aboud et al., 2013). Here, PTGS2 is linked to hepatocellular carcinoma.